Stryker (SYK)

Stryker operates in markets shaped by ageing populations, rising procedure volumes, hospital investment cycles, and demand for technologies that improve surgical precision and patient recovery. In reconstructive orthopedics, it competes with a small group of large global manufacturers that supply implants and related instruments to surgeons and hospitals. In operating room equipment, the company has a particularly strong position, offering items such as surgical lights, booms, communications systems, and related integration tools.

The business combines durable implant franchises with recurring demand for consumables, instruments, and replacement equipment. This gives Stryker exposure to both elective procedure trends and broader hospital capital spending. While the United States remains its largest market, the company also sells into international healthcare systems, with non-US revenue representing a meaningful share of total sales.

For investors, Stryker is typically viewed as a large-cap healthcare equipment company with a diversified product base, deep surgeon relationships, and exposure to long-term growth in musculoskeletal care, minimally invasive procedures, and hospital modernization.